(function(){ var content_array=["

About hemophilia and other bleeding disorders<\/strong><\/p>\r\n

Hemophilia, von Willebrand disease, inherited platelet disorders, and other factor deficiencies are lifelong bleeding disorders that prevent blood from clotting properly. People with bleeding disorders do not have enough of a particular clotting factor, a protein in blood that controls bleeding, or else it does not work properly. The severity of a person's bleeding disorder usually depends on the amount of clotting factor that is missing or not functioning. People with hemophilia can experience uncontrolled bleeding that can result from a seemingly minor injury. Bleeding into joints and muscles causes severe pain and disability while bleeding into major organs, such as the brain, can cause death.<\/p>\r\n

About BIOTEST AG<\/strong><\/p>\r\n

BIOTEST is a specialist in innovative hematology and immunology with the integrated approach of a pharmaceuticals and biotherapeutics group operating worldwide and develops, produces and sells medicinal products for the treatment of blood and immune disorders. The principal starting material for BIOTEST pharmaceuticals is human plasma, which is processed into medicinal products that are used in the treatment of life-threatening conditions such as coagulation disorders (hemophilia), severe infections or disorders of the immune system. Visit BIOTEST online at biotest.com<\/a>.<\/p>\r\n

About Canadian Blood Services<\/strong><\/p>\r\n

Canadian Blood Services is a national, not-for-profit charitable organization that manages the supply of blood and blood products in all provinces and territories outside of Quebec. Canadian Blood Services also oversees the OneMatch Stem Cell and Marrow Network, and provides national leadership for organ and tissue donation and transplantation. Canadian Blood Services operates 42 permanent collection sites and more than 20,000 donor clinics annually. The provincial and territorial Ministries of Health provide operational funding to Canadian Blood Services. The federal government, through Health Canada, is responsible for regulating the blood system.<\/p>\r\n

About the Canadian Hemophilia Society<\/strong><\/p>\r\n

Founded in 1953, the Canadian Hemophilia Society (CHS) is a national voluntary health charity. Its mission is to improve the health and quality of life of all people with inherited bleeding disorders and ultimately to find a cure. Its vision is a world free from the pain and suffering of inherited bleeding disorders. The CHS is a founding member of the World Federation of Hemophilia. Visit the CHS online at www.hemophilia.ca<\/a>.<\/p>\r\n

About GRIFOLS<\/strong><\/p>\r\n

GRIFOLS improves people's lives with high quality innovative hospital products and services. The plasma-derived therapies have outstanding records of efficacy and safety and GRIFOLS is also a world-leading manufacturer of medical devices, analyzers and reagents used by blood banks, transfusion centers, and clinical laboratories. GRIFOLS is one of two custom plasma fractionators for Canadian Blood Services.<\/p>\r\n

About the World Federation of Hemophilia<\/strong><\/p>\r\n

For 50 years, the World Federation of Hemophilia (WFH), an international not-for-profit organization, has worked to improve the lives of people with hemophilia and other inherited bleeding disorders. Established in 1963, it is a global network of patient organizations in 122 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org<\/a>.<\/p>\r\n

For further information:<\/p>\r\n

World Federation of Hemophilia<\/strong>
Sarah Ford
+1 514 266-7764
sford@wfh.org<\/a>
www.wfh.org<\/a><\/p>\r\n

Canadian Hemophilia Society<\/strong>
Chantal Raymond
+1 514 848-0503 #226
craymond@hemophilia.ca<\/a>
www.hemophilia.ca<\/a><\/p>"]; $("#dvExtra").html(content_array[0]);})();